VR-CAP in the First-line Treatment for Patients With Marginal Zone Lymphoma
Henan Cancer Hospital
Henan Cancer Hospital
National Taiwan University Hospital
Jichi Medical University
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Technical University of Munich
National Cancer Institute (NCI)
Heidelberg University
National Cancer Institute (NCI)